Manufacturing & Contract Manufacturing Sample only · Reservations open Page created Feb 7, 2026

List of GMP-Certified Peptide Synthesis Contract Manufacturers

List of cGMP-certified CDMOs offering peptide API synthesis for clinical and commercial supply. Ideal for pharma/biotech CMC teams sourcing outsourced peptide manufacturing partners.

Fields we plan to include

Company Name
Headquarters
GMP Certifications
Synthesis Scale (SPPS Capacity)
Annual Production Capacity
Regulatory Inspections Passed
Clinical Phase Support
Peptide Modifications Offered
Global Facility Locations
Key Therapeutic Areas

Data Preview

* Free sample rows, unverified and may contain errors. The full list isn't available yet.
Company NameHeadquartersGMP CertificationsAnnual Production Capacity
Bachem AGBubendorf, SwitzerlandFDA, EMA, PMDA>1 metric ton/year
PolyPeptide GroupBaar, SwitzerlandFDA, EMA, KFDAMulti-kg to metric ton scale
CordenPharma InternationalBasel, SwitzerlandFDA, EMA (HLfGP)42,000 L SPPS capacity (by 2028)
AmbioPharmNorth Augusta, SC, USAFDA (5 inspections passed)Up to 1 metric ton/year
CPC ScientificSunnyvale, CA, USAFDA, NMPA, EMA, TGA>1,000 kg/year

Estimated ~85 entries. We'll only compile the full list if enough people reserve it.

* No charge now. Purchase is optional.

GMP-Certified Peptide Synthesis: The CDMO Landscape

The global peptide therapeutics CDMO market surpassed USD 3.8 billion in 2024 and is projected to reach USD 16.7 billion by 2032, driven by the surge in GLP-1 agonists, peptide-drug conjugates, and over 170 peptide candidates currently in clinical trials. For CMC directors at pharma and biotech companies, identifying the right GMP-certified contract manufacturer is a critical path decision that directly impacts IND timelines and commercial supply security.

Capacity Expansion Race

The industry is experiencing an unprecedented capacity build-out. CordenPharma announced a EUR 900 million investment to more than double its SPPS reactor capacity to 42,000 L by 2028. Bachem is constructing a new large-scale facility in Bubendorf, Switzerland, alongside expansions at its Vista, CA site. PolyPeptide Group invested approximately EUR 100 million in modular expansion at its Malmö, Sweden facility, doubling SPPS capacity. These expansions reflect the structural supply deficit created by the commercial success of semaglutide and tirzepatide.

Key Selection Criteria for CMC Teams

CriterionWhy It Matters
Regulatory track recordFDA/EMA inspection history directly correlates with filing risk
Scale flexibilityToxicology batch (grams) to commercial supply (metric tons) under one roof
Technology platformSolid-phase (SPPS), solution-phase, hybrid, or continuous flow capabilities
Analytical & CMC supportIn-house method development, stability studies, and regulatory filing support
Supply chain resilienceMulti-site manufacturing, raw material sourcing, and geographic diversification

Regional Landscape

North America and Europe account for over 85% of global GMP peptide manufacturing capacity. Switzerland alone hosts the headquarters of three of the top five CDMOs (Bachem, PolyPeptide, CordenPharma). The Asia-Pacific region is gaining ground, with players like Sinopep Biopharma and GenScript scaling GMP capabilities to serve global sponsors.

Frequently Asked Questions

Q.Where does the data come from?

Full lists would be compiled from public sources such as official registries, industry association rosters and company websites. The sample rows on each page come from web searches and are unverified. Organization info only — no personal contact details.

Q.Is the full list available now?

Not yet. Sample rows are free. We only compile a full list if enough people reserve it. If we do, we'll email everyone who reserved it a purchase link (buying is optional). If we don't, nothing happens and you're never charged.

Q.What does it cost?

Sample rows are free. A full list is $49, paid only if we compile it and you decide to buy. There is no free trial or subscription.

Q.What format is it delivered in?

CSV (opens in Excel or Google Sheets). There is no API.